Tumor-Targeting with Stimuli-Responsive Vesicular Nanocarriers
Basics to Emerging Applications
- 1st Edition - May 1, 2025
- Editors: Ankit Jain, Nishit Mody, Srinath Palakurthi
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 1 2 5 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 1 2 6 - 5
Tumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not only acquaints scientists and science interns with the fundamental knowle… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteTumour-Targeting with Stimuli Responsive Vesicular Nanocarriers: Basics to Emerging Applications not only acquaints scientists and science interns with the fundamental knowledge of the experimental aspects and state-of-the-art technology for vesicular carriers to equip their rational application in tumor targeting, but also provides a holistic understanding of regulatory concerns, patents, and clinical trials. In 15 chapters. this book provides basics and advances in stimuli-responsive vesicular carriers for tumor targeting based on findings outlined in highly organized tables, illustrative figures, and flow charts.
With a focus on the extrapolation of bioengineering tools in the domain of vesicular carriers, stimuli-responsive features concerning tumors, drug delivery approaches, and associated challenges, it helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries in therapy, diagnosis, and theragnosis of cancer.
With a focus on the extrapolation of bioengineering tools in the domain of vesicular carriers, stimuli-responsive features concerning tumors, drug delivery approaches, and associated challenges, it helps readers to define the major gaps in knowledge that can lead to significant scientific discoveries in therapy, diagnosis, and theragnosis of cancer.
- Addresses the unmet needs and challenges confronted by nanotechnologists to foster collaboration of biologists, chemists, physicists, bioengineers, and clinicians
- Provides an explicit account of vital aspects of PEGylation of these carriers and challenges for effective tumor targeting
- Presents a need-of-hour discussion over regulatory concerns, clinical trials, and patents
Researchers working across the biosciences in the fields of oncology, pharmaceutical, and other nanomedicine drug delivery-related disciplines
1. Anomalous tumour microenvironment: exploitable features for drug delivery
2. Vesicular carriers for stimuli-responsive drug delivery to tumours: design considerations
3. Role of dePEGylation in vesicular carriers mediated stimuli-responsive drug delivery to tumours
4. pH-responsive vesicular carriers as promising tools for tumour targeting
5. Enzyme-responsive vesicular carriers as an emerging approach for tumour targeting
6. Redox-responsive vesicular carriers for potential tumour-targeting applications
7. Hypoxia-responsive vesicular carriers for enhanced tumour targeting
8. Magnetically responsive and thermo-responsive vesicular carriers for improved drug delivery to tumours
9. Ultrasound-responsive vesicular carriers for tumour targeting
10. Light-triggered vesicular carriers for tumour targeting
11. Electro- and Mechano-responsive vesicular carriers targeting tumours
12. Emerging applications of stimuli-responsive novel vesicular carriers: Exosomes, supramolecular vesicles, and catanionic vesicles
13. Vesicular carriers with multipronged features for diagnostics and theranostics
14. Nanotoxicity and challenges in stimuli-responsive vesicular carriers targeting tumour
15. Patents, clinical trials, and regulatory concerns with stimuli-responsive vesicular carriers.
2. Vesicular carriers for stimuli-responsive drug delivery to tumours: design considerations
3. Role of dePEGylation in vesicular carriers mediated stimuli-responsive drug delivery to tumours
4. pH-responsive vesicular carriers as promising tools for tumour targeting
5. Enzyme-responsive vesicular carriers as an emerging approach for tumour targeting
6. Redox-responsive vesicular carriers for potential tumour-targeting applications
7. Hypoxia-responsive vesicular carriers for enhanced tumour targeting
8. Magnetically responsive and thermo-responsive vesicular carriers for improved drug delivery to tumours
9. Ultrasound-responsive vesicular carriers for tumour targeting
10. Light-triggered vesicular carriers for tumour targeting
11. Electro- and Mechano-responsive vesicular carriers targeting tumours
12. Emerging applications of stimuli-responsive novel vesicular carriers: Exosomes, supramolecular vesicles, and catanionic vesicles
13. Vesicular carriers with multipronged features for diagnostics and theranostics
14. Nanotoxicity and challenges in stimuli-responsive vesicular carriers targeting tumour
15. Patents, clinical trials, and regulatory concerns with stimuli-responsive vesicular carriers.
- No. of pages: 240
- Language: English
- Edition: 1
- Published: May 1, 2025
- Imprint: Academic Press
- Paperback ISBN: 9780443291258
- eBook ISBN: 9780443291265
AJ
Ankit Jain
Dr. Ankit Jain is currently working as a Postdoctoral Research Associate at Texas A&M University School of Pharmacy, Texas. He completed his B. Pharm. (2006-09), M. Pharm. (Pharmaceutics, 2009-11), and Ph.D. (2012-17). Dr. Jain has been exploring different vesicular carriers viz. liposomes, niosomes, and micelles for the last eleven years. He has earmarked an appreciation for his outstanding performance in academics. He has been conferred with the “MP Young Scientist Award- 2017”. He has published 60 International publications in journals of high repute (Citations = 2500+, h-index = 21, and I10-index = 55) along with 25 book chapters in International Books. He is a reviewer and editorial board member of different renowned journals of international publishers An overarching goal of his current research is the development of nano-engineered drug delivery systems for various diseases with a prime focus on cancer
Affiliations and expertise
Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, Texas, USANM
Nishit Mody
Dr. Nishi Mody is presently working as a Guest Lecturer in the Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar (M.P). She possesses a Gold Medal in B. Pharm. and M. Pharm and was awarded DST-INSPIRE for her Ph.D. She has a good number of publications (22) published in peer-reviewed International Journals with high impact factors (Biotechnology Advances, Nanomedicine, etc.) and many book chapters (23) in international books. She has been awarded many prestigious awards including M.P. Young Scientist Award-2020, the Pharmaceutical Science Alumni Award consecutively for two years (2007 and 2008), Prof. C. S. Chauhan Gold Medal (2009), IDMA J.B. Mody Award (2009) and Nagarjuna Award (2011) for her excellent academic performance in U.G. and P.G. programs... Her area of research is focused on nanofabrications of polymeric and vesicular systems for cancer treatment with recent advances in the state-of-art of her domain
Affiliations and expertise
Department of Pharmaceutical Science, Dr. Hari Singh Gour University, Sagar, Madhya Pradesh, IndiaSP
Srinath Palakurthi
Prof. Srinath Palakurthi is a Professor at Irma Lerma Rangel School of Pharmacy at Texas A&M University, Kingsville, Texas. He has a strong background in drug delivery and pharmacokinetics with expertise in particulate and vesicular carrier systems for targeted drug and gene delivery applications. His research group has been working on different targeted drug delivery systems for cancer with a focus on combination therapy. He is the recipient of many prestigious awards including President’s Excellence Research Fund, Texas A& M University (2018), Academic Research Fellow, American Association of Colleges of Pharmacy (AACP) (2015), Governor’s 2010 Initiative (2005-2010), Research Centres Program, SD (2010), Governor’s 2010 Individual Research Seed Grant, SD (2005). Professor Palakurthi has a good number of publications in journals of high international repute.
Affiliations and expertise
Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, Texas, USA